Detalhe da pesquisa
1.
Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
Pediatr Blood Cancer
; : e31006, 2024 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616361
2.
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.
Blood
; 138(13): 1137-1147, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951732
3.
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.
Blood
; 137(8): 1050-1060, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959058
4.
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Pediatr Hematol Oncol
; 40(2): 147-158, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838057
5.
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Haematologica
; 107(10): 2329-2343, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021602
6.
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 69(1): e29313, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472213
7.
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(12): e29281, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596937
8.
CREBBP alterations are associated with a poor prognosis in de novo AML.
Blood
; 141(17): 2156-2159, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634304
9.
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
Blood
; 129(23): 3051-3058, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28411282
10.
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.
Blood
; 129(25): 3304-3313, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389462
11.
Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
J Pediatr Hematol Oncol
; 41(1): 51-55, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30095694
12.
Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.
Blood
; 135(18): 1603-1606, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187354
13.
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Blood
; 125(3): 516-24, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395418
14.
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.
Haematologica
; 102(12): 2058-2068, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28883080
15.
Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 64(12)2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453910
16.
Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
Int J Cancer
; 139(9): 1930-5, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27312107
17.
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Blood
; 124(15): 2400-7, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145343
18.
The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia.
Haematologica
; 106(2): 630-634, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381579
19.
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Pediatr Blood Cancer
; 63(12): 2096-2103, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511899
20.
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Blood
; 121(18): 3573-7, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23471307